Abstract
The treatment of a jaundiced patient with hyperbilirubinaemia due to breast cancer liver metastases is still a challenging problem. The associated hepatic dysfunction often represents a limiting factor for delivering standard dose chemotherapy. We report on the successful treatment of a jaundiced patient with excessive, recurrent liver metastases from breast cancer, using a combined chemotherapy of mitomycin and 5-fluorouracil after endoscopic stenting of the common bile duct.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms / pathology*
-
Combined Modality Therapy
-
Common Bile Duct* / pathology
-
Common Bile Duct* / surgery
-
Constriction, Pathologic / surgery
-
Endoscopy
-
Female
-
Fluorouracil / administration & dosage
-
Humans
-
Hyperbilirubinemia / etiology
-
Hyperbilirubinemia / surgery
-
Liver Neoplasms / complications
-
Liver Neoplasms / secondary*
-
Liver Neoplasms / therapy*
-
Middle Aged
-
Mitomycin / administration & dosage
-
Palliative Care*
-
Stents*